BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14561846)

  • 1. Pharmacogenetic considerations in diseases of cardiac ion channels.
    Anantharam A; Markowitz SM; Abbott GW
    J Pharmacol Exp Ther; 2003 Dec; 307(3):831-8. PubMed ID: 14561846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mutations in the heart's pacemaker channels--a new cause of sick sinus node syndrome and long-QT syndrome].
    Vitved T; Lianee HT; Støvring B; Sigurd BM; Christiansen M
    Ugeskr Laeger; 2008 Mar; 170(11):929-33. PubMed ID: 18397618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview.
    Smits JP; Blom MT; Wilde AA; Tan HL
    Expert Opin Pharmacother; 2008 Mar; 9(4):537-49. PubMed ID: 18312156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty single-nucleotide polymorphisms in four genes encoding cardiac ion channels.
    Iwasa H; Kurabayashi M; Nagai R; Nakamura Y; Tanaka T
    J Hum Genet; 2002; 47(4):208-12. PubMed ID: 12166659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Failure of antiarrhythmia agents and understanding the phenomenon of proarrhythmia].
    Semrád B
    Vnitr Lek; 2003 Sep; 49(9):700-6. PubMed ID: 14584417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the genes KCND2 and KCND3 encoding the ion channels Kv4.2 and Kv4.3, conducting the cardiac fast transient outward current (ITO,f), are not a frequent cause of long QT syndrome.
    Frank-Hansen R; Larsen LA; Andersen P; Jespersgaard C; Christiansen M
    Clin Chim Acta; 2005 Jan; 351(1-2):95-100. PubMed ID: 15563876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTS techniques to investigate the potential effects of compounds on cardiac ion channels at early-stages of drug discovery.
    Netzer R; Bischoff U; Ebneth A
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):462-9. PubMed ID: 12951809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias.
    Furukawa T; Kurokawa J
    Pharmacol Ther; 2007 Jul; 115(1):106-15. PubMed ID: 17583354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of potassium currents in cardiac arrhythmias.
    Ravens U; Cerbai E
    Europace; 2008 Oct; 10(10):1133-7. PubMed ID: 18653669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do defects in ion channel glycosylation set the stage for lethal cardiac arrhythmias?
    Fozzard HA; Kyle JW
    Sci STKE; 2002 Apr; 2002(130):pe19. PubMed ID: 11983936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term amiodarone administration remodels expression of ion channel transcripts in the mouse heart.
    Le Bouter S; El Harchi A; Marionneau C; Bellocq C; Chambellan A; van Veen T; Boixel C; Gavillet B; Abriel H; Le Quang K; Chevalier JC; Lande G; Léger JJ; Charpentier F; Escande D; Demolombe S
    Circulation; 2004 Nov; 110(19):3028-35. PubMed ID: 15520326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics and cardiac ion channels.
    Roepke TK; Abbott GW
    Vascul Pharmacol; 2006 Feb; 44(2):90-106. PubMed ID: 16344000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics in biological perspective.
    Kalow W
    Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Channel structure and drug-induced cardiac arrhythmias.
    Kass RS; Cabo C
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11683-4. PubMed ID: 11050193
    [No Abstract]   [Full Text] [Related]  

  • 15. Vulnerable substrate and multiple ion channel disorder in a diseased heart will be new targets for antiarrhythmic therapy.
    Dai DZ
    Acta Pharmacol Sin; 2000 Apr; 21(4):289-95. PubMed ID: 11324452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it time to include ion channel diseases among cardiomyopathies?
    Corrado D; Basso C; Thiene G
    J Electrocardiol; 2005 Oct; 38(4 Suppl):81-7. PubMed ID: 16226080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrocardiogram in channel disorders].
    González-Hermosillo JA
    Arch Cardiol Mex; 2004; 74 Suppl 1():S79-83. PubMed ID: 15216752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of heart rate abnormality--special reference to myocardial ion channels].
    Mashiba H
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1331-40. PubMed ID: 7504038
    [No Abstract]   [Full Text] [Related]  

  • 19. Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes.
    Meadows LS; Isom LL
    Cardiovasc Res; 2005 Aug; 67(3):448-58. PubMed ID: 15919069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
    Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
    Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.